Gail K Strickler
Scientist
Profile
A Senior Research Associate at the Schneider Institutes for Health Policy, Dr. Strickler earned a doctoral degree in Social Policy and a Master’s degree in Management of Human Services from the Heller School for Social Policy and Management. She has been a PEW Health Policy Fellow and a National Institute on Alcohol Abuse and Alcoholism (NIAAA) trainee in the doctoral program at the Heller School. Her primary research interests include program evaluation and systems of health care for disadvantaged populations, including individuals with substance abuse disorders and/or disabilities, as well as other underserved persons.
She has over twenty-five years of experience at Brandeis conducting both qualitative and quantitative research on a variety of health policy issues. She is currently the Principal Investigator on the Massachusetts Department of Public Health's PDMP Analysis Project and recently the Principal Investigator on the BJA-funded Comprehensive Opioid Abuse Program's Prescription Drug Monitoring Program (PDMP) Training and Technical Assistance Center, and Co-Principal Investigator on an study of effects of the 2017 New Jersey opioid prescribing laws. She recently served as Co-Principal Investigator of the Prescription Behavior Surveillance System (PBSS) project, as Project Manager on the CMS-funded evaluation of the Medicare Lifestyle Modification Project Demonstration and as Lead Investigator on Sections II and III of Substance Abuse: The Nation’s Number One Health Problem, a substance abuse chartbook funded by the Robert Wood Johnson Foundation. She was also Project Manager on a National Institute on Drug Abuse (NIDA) study on the cost-effectiveness of different types of substance abuse aftercare and co-investigator on a NIDA-funded study of gender and prescription drug abuse.
Scholarship
- Delcher C, Harris DR, Park C, Strickler GK, Talbert J, Freeman PR. "Doctor and pharmacy shopping”: A fading signal for prescription opioid use monitoring?." Drug and Alcohol Dependence 221. EPUB 2021 (2021): 108618. doi.org/10.1016/j.drugalcdep.2021.108618.
- Strickler GK, Kreiner PW, Halpin JF, Doyle E, Paulozzi LJ. "Opioid prescribing behaviors--Prescription Behavior Surveillance System, 11 states, 2010-2016." MMWR Surveillance Summary 69. 1 (2020): 1-20.
- Strickler GK, Zhang K, Halpin J, Bohnert A, Baldwin G, Kreiner K. "Effects of Mandatory Prescription Drug Monitoring Program (PDMP) Use Laws on Prescriber Registration and PDMP Use and on Risky Prescribing." Drug and Alcohol Dependence 199. (2019): 1-9.
- Garner BR, Lwin AK, Strickler GK, Hunter BD, Shepard DS. "Pay-for-performance as a cost-effective implementation strategy: Results of a cluster randomized trial." Implementation Science 13. 1 (2018): 92.
- Strickler, GK, Kreiner PK, Doyle E.. Trends in patient risk indicators of prescription opioid drug use and misuse and in prescription stimulant use in Massachusetts: 2011-2017. Waltham, MA Institute for Behavioral Health, Brandeis University: 2018.
- Kreiner PW, Strickler GK, Undurraga EA, Torres ME, Nikitin RV, Rogers A.. "Validation of prescriber risk indicators obtained from prescription drug monitoring program data." Drug and Alcohol Dependence 173. Supplement 1 (2017): S31-S38.
- Strickler, Gail K. "Trends in Indicators of Opioid Use and Misuse: Prescription Behavior Surveillance System (PBSS): Preliminary Results.." Addiction Health Services Research. Madison WI. 10/19/2017.
- Kreiner PW, Strickler GK, Undurrage EA, Torres ME, Nikitan RV. Validation study of prescriber risk indicators: Evidence from Maine using prescription drug monitoring programs. Waltham, MA The Institute for Behavioral Health, Brandeis University: 2016.
- Paulozzi LP, Strickler GK, Kreiner P, Koris CM. "Controlled substance prescribing patterns--Prescription Behavior Surveillance System--Eight states, 2013." Morbidity and Mortality Weekly Report Surveillance Summary 64. 9 (2015): 1-14.
- Strickler, Gail K.. "Prescription Behavior Surveillance System (PBSS): Controlled Substance Prescription Database for Public Health Epidemiology." 2015 International Symposium on Substance and Prescription Drug Abuse. Taipei. 09/02/2015.
- Kim ML, Thomas CP, Strickler GK, Kreiner P. "Prescription Behavior Surveillance System: Prescriber Initiatives." American Public Health Association. New Orleans. 11/18/2014.
- Razavi M, Fournier S, Shepard DS, Ritter G, Strickler, GK et al.. "Effects of Lifestyle Modification Programs on Cardiac Risk Factors." PLoS One 9. 12 (2014): 1-16.
- Strickler GK, Kreiner P, Panas L, Jones C, Paulozzi LP. "Development and Design of the Prescription Behavior Surveillance System: Preliminary Results." American Public Health Association. New Orleans. 11/18/2014.
- Strickler, GK. "Prescription Behavior Surveillance System: An Overview." PDMP Training and Technical Assistance Center Webinar Series. Waltham, MA. 4/16/2014.
- Zeng W, Stason WB, Fournier S, Razavi M, Ritter G, Strickler, GK, Bhalotra SM, Shepard DS. "Benefits and costs of intensive lifestyle modification programs for symptomatic coronary disease in Medicare beneficiaries." American Heart Journal 165. 5 (2013): 785-792.
- Clark, T, Eadie J, Kreiner P, Strickler G. Prescription Drug Monitoring Programs: An Assessment of the Evidence for Best Practices.. The PDMP Center of Excellence, Heller School for Social Policy and Management: 2012.
- Shepard DS, Zeng W, Strickler GK, Lwin AK, Cros MJ, Garner BR. "The Brief Treatment Cost Analysis Tool (TCAT-Lite) for Substance Abuse Treatment: Reliability, and Application." Alcoholism Treatment Quarterly 30. 4 (2012): 377-396.
- Strickler GK, Reif S, Horgan C, Acevedo A. "The Relationship between Substance Abuse Performance Measures and Mutual Help Group Participation after Treatment." Alcoholism Treatment Quarterly 30. 2 (2012): 190-210.
- Strickler GK, Reif S, Merrick EL, Horgan CM, Hiatt D. "Substance Abuse Treatment Preferences in an Employed Population." Journal of Workplace Behavioral Health 27. 2 (2012): 1-8.
- Larson MJ, Strickler GK, Brolin M, Fields S. "Lessons Learned: Leveraging Medicaid to Close the Addiction Treatment Gap.." Addiction Health Services Research (AHSR) Conference. Lexington, KY. October 2010.
- Strickler GK, Shepard DS, Hurley CL. "Heart Disease and Lifestyle Modification." Lifestyle Modification to Control Heart Disease. Ed. Shepard DS. Sudbury MA: Jones & Bartlett, 2010
- Razavi SM, Shepard DS, Bhalotra SM, Strickler GK, Ritter G, Stason WB. Effectiveness of the Lifestyle Modification Programs in Changing Behaviors of Elders. Final Report. CMS: 2009.